Clinical Trial Update: OnaBotulinumtoxin-A in Chronic Migraine Patients With Short or Long Disease History (the BACH Study)

View source ↗

Summary

This clinical trial update describes an ongoing study evaluating onabotulinumtoxinA (Botox) for chronic migraine, comparing outcomes in patients with short vers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico | Conditions: Migraine | Status: RECRUITING